檢索結果 - Simon Bornschein

  • Showing 1 - 9 results of 9
Refine Results
  1. 1
    The Long Non-coding RNA Flatr Anticipates Foxp3 Expression in Regulatory T Cells

    The Long Non-coding RNA Flatr Anticipates Foxp3 Expression in Regulatory T Cells 由 Aleksandra Brajic, Dean Franckaert, Oliver T. Burton, Simon Bornschein, A. Calvanese, Sofie Demeyer, Jan Cools, James Dooley, Susan Schlenner, Adrian Liston

    出版 2018
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  2. 2
    IL-2 consumption by highly activated CD8 T cells induces regulatory T-cell dysfunction in patients with hemophagocytic lymphohistiocytosis

    IL-2 consumption by highly activated CD8 T cells induces regulatory T-cell dysfunction in patients with hemophagocytic lymphohistiocytosis 由 Stéphanie Humblet‐Baron, Dean Franckaert, James Dooley, Simon Bornschein, Bénédicte Cauwe, Susann Schönefeldt, Xavier Bossuyt, Patrick Matthys, Frédéric Baron, Carine Wouters, Adrian Liston

    出版 2016
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  3. 3
    Brief Report: <i>IFIH1</i> Mutation Causes Systemic Lupus Erythematosus With Selective IgA Deficiency

    Brief Report: <i>IFIH1</i> Mutation Causes Systemic Lupus Erythematosus With Selective IgA Deficiency 由 Lien Van Eyck, Lien De Somer, Diana Pombal, Simon Bornschein, Glynis Frans, Stéphanie Humblet‐Baron, Leen Moens, Francis de Zegher, Xavier Bossuyt, Carine Wouters, Adrian Liston

    出版 2015
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  4. 4
    Correction: Mutant JAK3 phosphoproteomic profiling predicts synergism between JAK3 inhibitors and MEK/BCL2 inhibitors for the treatment of T-cell acute lymphoblastic leukemia

    Correction: Mutant JAK3 phosphoproteomic profiling predicts synergism between JAK3 inhibitors and MEK/BCL2 inhibitors for the treatment of T-cell acute lymphoblastic leukemia 由 Sandrine Degryse, Charles E. de Bock, Sofie Demeyer, Inge Govaerts, Simon Bornschein, Delphine Verbeke, Kris Jacobs, Steve Binos, David A. Skerrett‐Byrne, Heather C. Murray, Nicole M. Verrills, Pieter Van Vlierberghe, Jan Cools, Matthew D. Dun

    出版 2018
    獲取全文 獲取全文
    Errata/Corrigenda
    加到收藏夾
    Saved in:
  5. 5
    Mutant JAK3 phosphoproteomic profiling predicts synergism between JAK3 inhibitors and MEK/BCL2 inhibitors for the treatment of T-cell acute lymphoblastic leukemia

    Mutant JAK3 phosphoproteomic profiling predicts synergism between JAK3 inhibitors and MEK/BCL2 inhibitors for the treatment of T-cell acute lymphoblastic leukemia 由 Sandrine Degryse, Charles E. de Bock, Sofie Demeyer, Inge Govaerts, Simon Bornschein, Delphine Verbeke, Kris Jacobs, Steve Binos, David A. Skerrett‐Byrne, Heather C. Murray, Nicole M. Verrills, Pieter Van Vlierberghe, Jan Cools, Matthew D. Dun

    出版 2017
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  6. 6
    Cooperative Enhancer Activation by TLX1 and STAT5 Drives Development of NUP214-ABL1/TLX1-Positive T Cell Acute Lymphoblastic Leukemia

    Cooperative Enhancer Activation by TLX1 and STAT5 Drives Development of NUP214-ABL1/TLX1-Positive T Cell Acute Lymphoblastic Leukemia 由 Marlies Vanden Bempt, Sofie Demeyer, Michaël Broux, Jolien De Bie, Simon Bornschein, Nicole Mentens, Roel Vandepoel, Ellen Geerdens, Enrico Radaelli, Beat Bornhäuser, Andreas E. Kulozik, Jules P.P. Meijerink, Jean‐Pierre Bourquin, Charles E. de Bock, Jan Cools

    出版 2018
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  7. 7
    The Intracellular Sensor NOD2 Induces MicroRNA-29 Expression in Human Dendritic Cells to Limit IL-23 Release

    The Intracellular Sensor NOD2 Induces MicroRNA-29 Expression in Human Dendritic Cells to Limit IL-23 Release 由 Oliver Brain, Benjamin M. J. Owens, Tica Pichulik, Philip Allan, Elham Khatamzas, Alasdair Leslie, Tessa A. M. Steevels, Sameer Sharma, Alice Mayer, Ana Catuneanu, Victoria Hodgetts Morton, Meiyi Sun, Derek P. Jewell, Margherita Coccia, Oliver J. Harrison, Kevin J. Maloy, Susann Schönefeldt, Simon Bornschein, Adrian Liston, Alison Simmons

    出版 2013
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  8. 8
    The T-cell leukemia-associated ribosomal RPL10 R98S mutation enhances JAK-STAT signaling

    The T-cell leukemia-associated ribosomal RPL10 R98S mutation enhances JAK-STAT signaling 由 Tiziana Girardi, Stijn Vereecke, Sergey O. Sulima, Yousuf A. Khan, Laura Fancello, Joseph Briggs, Claire Schwab, Joyce Op de Beeck, Johan Verbeeck, Jonathan Royaert, Ellen Geerdens, Carmen Vicente, Simon Bornschein, Christine J. Harrison, Jules P.P. Meijerink, Jan Cools, Jonathan D. Dinman, Kim R. Kampen, Kim De Keersmaecker

    出版 2017
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  9. 9
    HOXA9 Cooperates with Activated JAK/STAT Signaling to Drive Leukemia Development

    HOXA9 Cooperates with Activated JAK/STAT Signaling to Drive Leukemia Development 由 Charles E. de Bock, Sofie Demeyer, Sandrine Degryse, Delphine Verbeke, Bram Sweron, Olga Gielen, Roel Vandepoel, Carmen Vicente, Marlies Vanden Bempt, Antonis Dagklis, Ellen Geerdens, Simon Bornschein, Rik Gijsbers, Jean Soulier, Jules P.P. Meijerink, Merja Heinäniemi, Susanna Teppo, Maria Bouvy‐Liivrand, Olli Lohi, Enrico Radaelli, Jan Cools

    出版 2018
    獲取全文
    Artigo
    加到收藏夾
    Saved in:

檢索工具: